Quantcast
Home » Topics » stent thrombosis

New drug ‘reduces mortality of heart patients’

The anti-clotting drug Rivaroxaban lowers risk of death, heart attack and stroke in acute coronary syndrome patients, according to a new study. The study presented at a meeting of the American Heart Associationin Orlando, Florida, Sunday concluded that patients who took Rivaroxaban had a 16-percent reduced risk of cardiovascular death, stroke or heart attack compared to patients who didn’t.…

Google+